The trial assessed the graphene-based cortical interface during neurosurgical procedures for brain tumour resection.
INBRAIN Neuroelectronics, a neurotechnology company developing graphene-based brain-computer interface therapeutics (BCI-Tx), ...
InBrain Neuroelectronics announced today that it completed patient recruitment in a first-in-human brain-computer interface ...
Spain-based INBRAIN Neuroelectronics has completed patient recruitment for its first-in-human study evaluating a ...
BARCELONA, Spain, June 23, 2025--(BUSINESS WIRE)--INBRAIN Neuroelectronics, a clinical-stage neurotechnology company developing precision brain-computer interfaces (BCIs) powered by graphene, today ...
BARCELONA, Spain--(BUSINESS WIRE)--INBRAIN Neuroelectronics S.L., a company in the intersection between Medtech, Deeptech and Digital Health dedicated to developing the world’s first intelligent ...
Spain-based INBRAIN Neuroelectronics, a company specialising in graphene-based brain-computer interface (BCI) technologies, has secured $50m (€46m) in a Series B financing round, aimed at advancing ...
Elon Musk's Neuralink has a new competitor It's a startup company called Inbrain Neuroelectronics It says its chips are made of one of the strongest materials ever tested It aims to cure brain ...
Lille, May 12, 2025 - InBrain Pharma, a clinical stage biotech specialized in therapeutic solution development against neurodegenerative diseases, is thrilled to announce that it has been selected as ...